153 related articles for article (PubMed ID: 19625376)
1. A new role for vitamin D receptor activation in chronic kidney disease.
Valdivielso JM; Cannata-Andía J; Coll B; Fernández E
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1502-9. PubMed ID: 19625376
[TBL] [Abstract][Full Text] [Related]
2. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
3. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
Covic A; Voroneanu L; Goldsmith D
Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
[TBL] [Abstract][Full Text] [Related]
4. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Effect of vitamin D on kidney and cardiovascular system].
Fujii H
Clin Calcium; 2010 Jul; 20(7):1045-50. PubMed ID: 20585183
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and treatment of vascular calcification in CKD].
Brancaccio D; Gallieni M; Pasho S; Fallabrino G; Olivi L; Volpi E; Ciceri P; Missaglia E; Ronga C; Brambilla C; Butti A; Rocca-Rey L; Chiarelli G; Cozzolino M
G Ital Nefrol; 2009; 26 Suppl 45():S20-7. PubMed ID: 19382090
[TBL] [Abstract][Full Text] [Related]
6. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
Cunningham J; Locatelli F; Rodriguez M
Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
[TBL] [Abstract][Full Text] [Related]
7. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Sprague SM; Coyne D
Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
[TBL] [Abstract][Full Text] [Related]
8. Vascular calcification in patients with chronic kidney disease.
Nitta K
Ther Apher Dial; 2011 Dec; 15(6):513-21. PubMed ID: 22107687
[TBL] [Abstract][Full Text] [Related]
9. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Inaguma D; Tatematsu M
Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
[TBL] [Abstract][Full Text] [Related]
10. Vascular calcification in chronic kidney failure: role of vitamin D receptor.
Wu-Wong JR; Melnick J
Curr Opin Investig Drugs; 2007 Mar; 8(3):237-47. PubMed ID: 17408120
[TBL] [Abstract][Full Text] [Related]
11. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
12. The role of vitamin D in vascular calcification in chronic kidney disease.
Wolisi GO; Moe SM
Semin Dial; 2005; 18(4):307-14. PubMed ID: 16076354
[TBL] [Abstract][Full Text] [Related]
13. Secondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.
Hudson JQ
Ann Pharmacother; 2006 Sep; 40(9):1584-93. PubMed ID: 16912241
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
Agarwal R
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
[TBL] [Abstract][Full Text] [Related]
15. Mineral metabolism disturbances in patients with chronic kidney disease.
Kestenbaum B; Belozeroff V
Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
17. [Cardioprotective effect of vitamin D in nondialyzed patients with stage 3-5 CKD].
Cozzolino M; Mehmeti F; Bonelli F; Ronga C; Musetti C; Missaglia E; Stucchi A; Colombo F; Tavecchia M; Cuoccio P; Brenna I; Volpi E; Ciceri P; Cusi D
G Ital Nefrol; 2010; 27 Suppl 52():S27-31. PubMed ID: 21132659
[TBL] [Abstract][Full Text] [Related]
18. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
Mizobuchi M; Aoshima Y; Akizawa T
Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D therapy for chronic kidney disease.
Bhan I; Thadhani R
Semin Nephrol; 2009 Jan; 29(1):85-93. PubMed ID: 19121478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
